Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1155 CHF | +0.43% | -23.26% | +151.09% |
Apr. 24 | Top Premarket Decliners | MT |
Apr. 18 | Transcript : Addex Therapeutics Ltd, 2023 Earnings Call, Apr 18, 2024 |
Sales 2024 * | - | Sales 2025 * | 10.75M 11.79M | Capitalization | 14.75M 16.18M |
---|---|---|---|---|---|
Net income 2024 * | -6M -6.58M | Net income 2025 * | - 0 | EV / Sales 2024 * | - |
Net cash position 2024 * | 362K 398K | Net cash position 2025 * | 7.23M 7.93M | EV / Sales 2025 * | 0.7 x |
P/E ratio 2024 * |
-1.28
x | P/E ratio 2025 * |
2.09
x | Employees | 23 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 50.48% |
Latest transcript on Addex Therapeutics Ltd
1 day | -4.35% | ||
1 week | -26.91% | ||
Current month | +15.06% | ||
1 month | +16.03% | ||
3 months | +22.22% | ||
6 months | +109.13% | ||
Current year | +139.13% |
Managers | Title | Age | Since |
---|---|---|---|
Tim Dyer
FOU | Founder | 56 | 01-12-31 |
Lénaic Teyssédou
DFI | Director of Finance/CFO | 38 | 17-05-31 |
Chairman | 75 | 09-04-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jake Nunn
BRD | Director/Board Member | 54 | 18-05-31 |
Tim Dyer
FOU | Founder | 56 | 01-12-31 |
Chairman | 75 | 09-04-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.1155 | +0.43% | 1 832 556 |
24-04-25 | 0.115 | -6.50% | 364,591 |
24-04-24 | 0.123 | -9.23% | 1,407,251 |
24-04-23 | 0.1355 | -12.01% | 1,412,204 |
24-04-22 | 0.154 | +2.33% | 496,464 |
Delayed Quote Swiss Exchange, April 26, 2024 at 06:03 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+139.13% | 16.15M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+47.53% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- ADXN Stock